Lung Cancer Clinical Trial
Official title:
A Prospective Randomized Multi-Centered Study and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures
The purpose of this study is to demonstrate safety and effectiveness of the Bio-Seal Biopsy Track Plug in a clinical setting for use in lung biopsy procedures to reduce the rate of air leaks, commonly associated with the procedure. The Bio-Seal System is cleared in the U.S. with an indication for use as a lung biopsy site marker.
Air leaks are the most common problem after a lung biopsy. Air leaks can be mild to severe.
Mild air leaks are monitored by chest x-ray and may go away by themselves. Air leaks can
cause pain and require repeated x-rays, and in some cases the need for a tube to be inserted
into the chest for drainage of the air.
If you agree to take part in this study, you will be randomly assigned (as in the toss of a
coin) to 1of 2 groups. Participants in one group will receive the experimental lung plug
after the lung biopsy. Participants in the other group will just have the standard lung
biopsy without placement of the plug. There is an equal chance of being assigned to either
group.
All participants will have the routine lung biopsy performed by their doctor with the aid of
a computerized tomography (CT) scan. During a lung biopsy, a needle is inserted into the
mass in the lung using the CT for guidance. A smaller needle is then inserted through the
first needle to collect a sample of the tissue.
If you are assigned to receive the lung plug, it will be inserted into the track left when
the biopsy needle is removed. The smaller sampling needle is removed, and the lung plug is
inserted through the larger needle using a delivery tool that has a plunger to push the plug
in place. The lung plug remains in the track left when the larger needle is removed.
Regardless of which group you are assigned to, you will be receive the same follow-up
treatment. The rates of air leaks after the lung biopsy will be compared between 2 groups of
participants. This will provide researchers with the data to learn if the lung plug should
be used for all patients receiving a lung biopsy to decrease the number of air leaks.
Your doctor will watch you carefully for air leaks. You will have a chest x-ray about 1 hour
after the procedure to again check for air leaks. If a leak is detected, you will receive
the normal treatment for air leaks, which includes chest x-rays on a regular basis. If the
air leak grows, you may need a chest tube placed for drainage. It is possible that this may
require you to stay in the hospital overnight. In the most extreme cases, additional surgery
may be needed to stop the air leak. Over time, your body will absorb the plug. A final x-ray
will be taken 1 month after the biopsy to be sure that an air leak has not developed.
You will be asked to be in the study for 30 days. This will include the time you spend in
the hospital for the biopsy and, if you have an air leak, the entire time you spend in the
hospital, if it needs to be treated. In addition, you will return to your doctor the day
following the biopsy and 30 days later to have a chest x-ray to look for any late air leaks.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|